BioSpace News Archive

TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimally Invasive Treatment of Tricuspid Regurgitation

TRiCares SAS is pleased to announce today the successful completion of a €22 Million ($25.4 Million) Series B financing round.

June 5, 2018
·
4 min read
Business

Sosei Announces Appointment of Chris Cargill as Interim CFO

Sosei Group Corporation announces that Mr. Andrew Oakley, Executive Vice President and CFO, has resigned from the Company.

June 5, 2018
·
2 min read
AYOXXA launches LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits to elucidate T cell differentiation

AYOXXA Biosystems GmbH announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits.

June 5, 2018
·
6 min read
Job Trends

MagForce AG to host Lunch Symposium about Local Therapies for Malignant Gliomas at the 2018 meeting of the German Society of Neurosurgery (DGNC)

MagForce AG is pleased to announce that it will host a scientific lunch symposium titled “Local Therapies for Malignant Gliomas” at the 69th Annual Meeting of the German Society of Neurosurgery (DGNC).

June 5, 2018
·
4 min read
Drug Development

Chi-Med Presents Further Fruquintinib FRESCO Trial Data at ASCO 2018 Annual Meeting

Hutchison China MediTech Limited announced that further data from the FRESCO Phase III study in 416 patients with locally advanced or metastatic colorectal cancer were presented at the 2018 American Society of Clinical Oncology Annual Meeting.

June 5, 2018
·
11 min read
FDA

Chugai’s HEMLIBRA® Receives Priority Review Status from U.S. FDA for Hemophilia A Without Inhibitors

Second Designation following Hemophilia A with inhibitors

June 5, 2018
·
3 min read
Business

Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Directors

New appointees bring extensive medical and commercial expertise to Gelesis as the company prepares for regulatory approval filings in the U.S. and Europe

June 5, 2018
·
6 min read
Job Trends

CENTOGENE to Open First U.S. Laboratory in Cambridge, MA Focused on Rare Genetic Diseases Diagnostics

The new facility, opening on August 1, 2018, will be the central point of contact for CENTOGENE’s collaboration partners that leverage its diagnostic services in the U.S.

June 5, 2018
·
2 min read
IQVIA Launches Commercial Content Management Solution IQVIA™ ePromo

Cloud-based solution accelerates and simplifies managing regulated promotional and non-promotional content for life sciences organizations

June 5, 2018
·
3 min read
BioForest

NASH – A Silent Killer: 150 World Experts Sign a Global Call to Action to Promote Awareness of Deadly Liver Disease

More than 150 global liver and metabolic disease experts issued today a call to action against the chronic liver disease nonalcoholic steatohepatitis (NASH).

June 5, 2018
·
14 min read